Plasma glycerol levels were highest, and AQP9 expression and glycerol permeability were reduced, in obese people with T2D and greater severity of liver disease, suggesting downregulation of AQP9 is a defensive mechanism (139). The gene discussed is AQP9; the disease is liver disorder.